Advertisement

Topics

BioMarker Strategies, LLC Company Profile

14:06 EST 11th December 2018 | BioPortfolio

BioMarker Strategies has developed SnapPath®, the only cancer diagnostics system that automates and standardizes functional ex vivo profiling of live solid tumor cells from fresh biopsies or other fresh, unfixed samples such as xenografts or tumorgrafts. SnapPath® can help guide cancer drug development and treatment selection. The Company’s PathMAP® Functional Signaling Profiles, created using the SnapPath® system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatment. PathMAP® Melanoma is currently in development as a companion diagnostic under a National Cancer Institute SBIR Phase II contract, the ultimate goal of which is to prepare for a clinical trial of PathMAP® Melanoma under a Phase IIB NCI contract. Patents for SnapPath® have been allowed and are proceeding to grant in Europe and Australia, and applications are pending in the U.S. and other countries. Patents for PathMAP® Functional Signaling Profiles have been allowed and are proceeding to grant in Australia and Singapore, and applications are pending in Europe, the U.S. and other countries. For more information about BioMarker Strategies, please see www.biomarkerstrategies.com.


News Articles [384 Associated News Articles listed on BioPortfolio]

New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker

A new review article has been published, Thymidine Kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker, that analyses and summarizes recent publications descr...

Potential New Biomarker for the Diagnosis of ALS

A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.

CTCs as a Predictive Biomarker in Suspected Ovarian Cancer

Might circulating tumor cells be useful as a diagnostic biomarker in women with complex pelvic masses? Laboratory Medicine

#jobs #lifescience BIOMARKER OPERATIONS LEADER

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BIOMARKER OPERATIONS LEADER .CA-South San Francisco, BIOMARKER OPERATIONS LEA...

Patient-Experienced Toxicity Is a Biomarker Worth Considering

Maurie Markman, MD, says that the acceleration in regulatory agency approvals for novel antineoplastic agents and the focus of biomarker discovery proves that this is the era of precision me...

No Silver-Bullet Biomarker for Precision RCC Care

Bryant FurlowJun 2, 2018No one molecular biomarker is likely to guide treatment of RCC in the foreseeable future. Multipredictor models might be a way forward, an expert concluded.

ASCO 2018: Roche discusses TMB as a predictive biomarker for NSCLC

Data from B-F1RST (NCT02848651), the first prospective study of blood tumor mutational burden (bTMB) as a biomarker for Roche’s Tecentriq...Read More... The post ASCO 2018: Roche discusses TMB as a ...

Autism biomarker may aid early diagnoses

A newly discovered group of blood metabolites could act as a biomarker to accelerate the diagnosis of autism spectrum disorder.

Drugs and Medications [10 Associated Drugs and Medications listed on BioPortfolio]

Plavix [Rebel Distributors Corp]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [Contract Pharmacy Services-PA]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [State of Florida DOH Central Pharmacy]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

Plavix [Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets Initial U.S. App...

PubMed Articles [1116 Associated PubMed Articles listed on BioPortfolio]

The future of protein biomarker research in type 2 diabetes mellitus.

The onset of Type 2 Diabetes Mellitus (T2DM) is strongly associated with obesity and subsequent perturbations in immuno-metabolic responses. To understand the complexity of these systemic changes and ...

Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F.

The widespread detection of elevated oxidative stress levels in many medical conditions has led to numerous efforts to design interventions to reduce its effects. Efforts have been wide-ranging, from ...

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances.

Biomarker detection is one of the more important biomedical questions for high-throughput 'omics' researchers, and almost all existing biomarker detection algorithms generate one biomarker subset with...

Feasibility of using urinary TDGA as a biomarker for VCM exposures.

Thiodiglycolic acid (TDGA) is a major metabolite of vinyl chloride monomer (VCM), and it has been suggested as an exposure biomarker for VCM. The validity of this biomarker when the level of VCM is le...

Integrated Multi-Omic Predictors for Ovarian Cancer Survival.

Increasingly affordable high-throughput molecular profiling technologies have made feasible the measurement of omics-wide interindividual variations for the purposes of predicting cancer prognosis. Wh...

Clinical Trials [3538 Associated Clinical Trials listed on BioPortfolio]

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue ma...

Evidence-based Screening Strategies for Celiac Disease

Main aim: To find evidence-based screening strategies for celiac disease in high risk groups and to find new biomarkers or biomarker combinations for celiac disease diagnostics and follow-...

Biomarker for Hurler Disease

Development of a new MS-based biomarker for the early and sensitive diagnosis of Hurler disease from plasma. Testing for clinical robustness, specificity and long-term stability of the bio...

Strategies to Enhance the Experience of Exercise

This study aims to test the effect of three cognitive strategies to affect individuals' subjective experience of cardiovascular exercise. Participants will be randomly assigned to one of t...

Guiding Evidence Based Therapy Using Biomarker Intensified Treatment

The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy compared with usual care in high risk patients with left ventricular systolic dysfunction.

Companies [637 Associated Companies listed on BioPortfolio]

BioMarker Strategies LLC

BioMarker Strategies is a privately-held molecular diagnostics company founded in 2006 at The Johns Hopkins Science & Technology Park in Baltimore, and now based in Rockville, Mar...

BioMarker Strategies, LLC

BioMarker Strategies has developed SnapPath®, the only cancer diagnostics system that automates and standardizes functional ex vivo profiling of live solid tumor cells from fre...

BioMarker Strategies

BioMarker Strategies (www.biomarkerstrategies.com) is a cancer diagnostics company that is developing a novel biomarker testing system to improve the treatment of cancer. SnapPath...

ABL, Inc. and Aushon BioSystems

Aushon BioSystems, Inc. is leading the way in protein biomarker discovery, development and analysis. Through the unique combination of proprietary microarray printing, extensive b...

BiomarkerBase

BiomarkerBase™ (http://www.biomarkerbase.com) includes every molecular biomarker on a drug label, every biomarker in a PMA-approved diagnostic, prognostic, or companion diagn...

More Information about "BioMarker Strategies, LLC" on BioPortfolio

We have published hundreds of BioMarker Strategies, LLC news stories on BioPortfolio along with dozens of BioMarker Strategies, LLC Clinical Trials and PubMed Articles about BioMarker Strategies, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMarker Strategies, LLC Companies in our database. You can also find out about relevant BioMarker Strategies, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record